We combine advanced diagnostics, traditional cardiovascular expertise, and guided integrative care to identify early risk, help reduce preventable events, and support safe, individualized decisions.
Many patients are embracing natural therapies in their journey to better health. We respect that. Our role is to bring structure, safety, and clinical judgment to those decisions while staying focused on prevention, early detection, and individualized care.
We are not replacing traditional care. We are identifying risk that traditional models often miss, especially in the preclinical phase, and helping patients navigate both conventional and integrative options with clarity.
Personalized cardiovascular evaluation with attention to hormones, metabolic health, prevention, and long-term vitality.
Comprehensive cardiovascular screening with attention to hormones, performance, vascular health, and preventive strategy.
Includes GLP-1-informed decision support, resting metabolic rate assessment, and fat burn zone strategy.
Ambulatory blood pressure monitoring, expanded biomarker assessment, and deeper evaluation of residual risk.
Not insurance-driven disease management, but personalized cardiovascular screening built around risk discovery.
High-touch cardiovascular review for leaders who want clarity, prevention, and continuity at a personal level.
Our model begins with executives and key personnel, then expands thoughtfully into broader employee and first responder populations.
Personalized cardiovascular intelligence for leadership teams, with early risk identification and individualized review.
Structured scaling model that extends prevention, screening, and data-informed risk visibility across larger employee populations.
Specialized cardiovascular risk reduction model designed for firefighters, law enforcement, and other high-stress public service teams.
Cardiovascular medicine is evolving rapidly. We are building a continuously learning model of care where clinical expertise, advanced diagnostics, and real-world data work together to improve outcomes.
AI, advanced biomarkers, and emerging diagnostic tools allow us to see risk earlier, act more precisely, and care more effectively.
We are committed to outcomes-driven research, real-world evidence generation, and thoughtful collaboration with leading innovators in cardiovascular diagnostics.
During his fellowship at Duke University Medical Center, Dr. Mark A. East studied physician decision-making and the factors that influence clinical judgment in cardiovascular care. This early work informs our current efforts.
Whether you are seeking a personalized cardiovascular evaluation, executive health strategy, or organizational prevention program, we can help.